Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 09 save search
AppHarvest named finalist for 2022 SXSW Innovation Awards
Published: 2022-03-09 (Crawled : 22:00) - globenewswire.com
APPH | $0.0666 -16.01% -11.53% 10M
|
|
| O: -7.53%
H: 26.51%
C: 25.12%
awards
NRx Pharmaceuticals Announces Leadership Transition
Published: 2022-03-09 (Crawled : 04:00) - prnewswire.com
NRXP | $4.38 -10.61% 140K
|
Manufacturing
|
| O: 5.12%
H: 32.58%
C: 23.6%
als ces
Yield10 Bioscience Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
YTEN | $0.288 2.13% 130K
|
Health Technology
|
| O: -4.32%
H: 36.57%
C: 21.9%
financial results bioscience results
red violet Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
RDVT | $18.29 0.83% 5.2K
|
Technology Services
|
| O: -0.85%
H: 33.16%
C: 19.5%
financial results ces results
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Metastatic Head and Neck Cancer
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
VCNX | $5.09 -16.56% 11K
|
Health Technology
|
| O: 1.83%
H: 18.92%
C: 17.12%
america ema phase 1b research presentation pepinemab phase 1 keytruda dating cancer head and neck vaccine phase 2b
Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Meta
Published: 2022-03-09 (Crawled : 16:20) - ir.vaccinex.com
VCNX | $5.09 -16.56% 11K
|
Health Technology
|
| O: 1.83%
H: 18.92%
C: 17.12%
america ema phase 1b research presentation pepinemab phase 1 keytruda dating cancer vaccine phase 2b
Registration of Share Capital Increase in IDEX Biometrics - 9 March 2022
Published: 2022-03-09 (Crawled : 11:00) - globenewswire.com
IDBA | $4.88 1.67% 0.0% 9
|
Manufacturing
|
| O: 1.39%
H: 16.84%
C: 16.84%
Ampio Pharmaceuticals to Participate at the 34th Annual Roth Conference
Published: 2022-03-09 (Crawled : 14:30) - ampiopharma.com
AMPE | $0.62 53K
|
Health Technology
|
| O: 2.62%
H: 13.69%
C: 13.69%
als conference
9 Meters Biopharma to Present at the Oppenheimer 32nd Annual Healthcare Conference
Published: 2022-03-09 (Crawled : 14:00) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: 0.12%
H: 14.21%
C: 12.22%
health biopharma thc conference
Mark Borman appointed Chairman of the Board of USRM
Published: 2022-03-09 (Crawled : 14:30) - us-stemcell.com
USRM | $0.0001 1300.0% 290K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 28.38%
C: 12.16%
air
Vera Bradley Announces Fourth Quarter and Fiscal Year 2022 Results
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
VRA A | $6.425 0.86% 85K
|
Consumer Non-Durables
|
| O: -7.07%
H: 15.37%
C: 12.04%
ces results
Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
XGN | $1.375 -3.85% 49K
|
Health Services
|
| O: 2.5%
H: 10.69%
C: 10.55%
life science
Palisade Bio (Nasdaq: PALI) to Present New Clinical Data of LB1148 for Preventing Adhesions in Conjunction with Next Big Thing Session at Society of American Gastrointestinal and Endoscopic Surgeons 2022 Annual Meeting
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
PALI | $6.5 56.25% 22M
|
Manufacturing
|
| O: 0.01%
H: 11.63%
C: 10.44%
lb1148 america gastrointestinal nasdaq test
Alector to Present at Upcoming Healthcare Conferences
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
ALEC | $5.4 -4.26% 81K
|
Health Technology
|
| O: 2.24%
H: 13.13%
C: 9.99%
health thc conference
TATAA Biocenter partners with Olink to add high quality proteomics with unrivaled throughput to their multi-omics offering
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
OLK | $22.75 0.04% 260K
|
Manufacturing
|
| O: 2.11%
H: 10.59%
C: 9.82%
offering olink
AgroFresh Solutions Reports Results for Fourth Quarter and Full Year 2021
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
AGFS | $3.0 -0.27% 0
|
Process Industries
|
| O: -2.03%
H: 20.73%
C: 9.59%
solutions report results
Uranium Expected To Take On Bigger Role As Energy Transition Metal In 2022
Published: 2022-03-09 (Crawled : 14:00) - prnewswire.com
SYHBF | $0.34 120K
|
Non-Energy Minerals
|
| O: -0.38%
H: 17.8%
C: 4.19%
CCJ | $48.29 -0.06% 3M
|
Non-Energy Minerals
|
| O: 0.78%
H: 11.88%
C: 9.51%
energy uranium
C4 Therapeutics Announces FDA Orphan Drug Designation for CFT8634 for the Treatment of Soft Tissue Sarcoma
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
CCCC | $6.84 -0.29% 650K
|
Health Technology
|
| O: 5.67%
H: 11.76%
C: 9.1%
cft8634 treatment fda drug therapeutics drug designation orphan drug designation soft tissue
Africa & Middle East Prepaid Card and Digital Wallet Market Databook 2022: Market Size and Forecast, Consumer Attitude & Behaviour, Retail Spend, 2017-2021 & 2022-2026
Published: 2022-03-09 (Crawled : 13:00) - prnewswire.com
KKOYY | $8.87 3.9K
|
Retail Trade
|
| O: 3.97%
H: 9.08%
C: 9.08%
HNNMY | $2.96 42K
|
Retail Trade
|
| O: 7.89%
H: 1.11%
C: 0.0%
wall africa
DatChat Receives Notice of Allowance for Blockchain-Based Communication Systems and Methods
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
DATS | $1.17 38K
|
|
| O: 1.31%
H: 12.22%
C: 9.03%
system blockchain communication
Gainers vs Losers
| 53% | 47% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.